Frontiers | Does the kappa opioid receptor system contribute to pain aversion?
Pathways and Receptors – Opioid Peptides
κ-opioid receptor - Wikipedia
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Structure of the human κ-opioid receptor in complex with JDTic | Nature
Activation of opioid receptors in the enteric nervous system. MOR mu... | Download Scientific Diagram
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Study targets kappa opioid receptor to develop more effective drugs for pain management | Anesthesiology | Washington University School of Medicine in St. Louis
Opioids in cancer: The κ‑opioid receptor (Review)
opioid receptor (English) - Medical terminology for medical students - - YouTube
RETRACTED ARTICLE: Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
Top: Distribution of kappa opioid (7-transmembrane receptor), estrogen,... | Download Scientific Diagram
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Green Fluorescent Kappa Opioid Receptor Cell Line - Innoprot Cell Lines
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Opioid receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
Opioids in cancer: The κ‑opioid receptor (Review)
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports